CAB Case Studies from Ethiopia
A framework to support new product introduction in national health systems
Resource Library
- May 31, 2023
Optimal CAB Case Study: Pediatric Dolutegravir
- Feb 27, 2023
Community Statements on DRV/r Use in 2L
- Feb 16, 2023
CAB Case Studies from Tanzania
- Feb 16, 2023
CAB Case Studies from Zambia
- Feb 16, 2023
CAB Case Studies from Nigeria
- Feb 16, 2023
CAB Case Studies from Uganda
- Oct 18, 2022
Prevention Product Preference Brief
- Oct 18, 2022
CAB-LA Community Meeting Overview
- Sep 12, 2022
AHD Community Advocacy Video
- Sep 12, 2022
Pediatric DTG Advocacy Video for Communities (English and French)
- Jul 31, 2022
Optimal CAB Case Study: Enabling and Ensuring Equitable HIV Treatment for Women
- Jul 31, 2022
Case Study: Community-Developed HIV Care and Treatment Literacy Improves Uptake of Optimal Medicines
- Jun 16, 2022
AHD Social Media Campaign
- Oct 18, 2021
The Community's Corner: Optimal CAB Newsletter
- Jul 9, 2021
Community Resources for Pediatric DTG Scale-Up
- Aug 1, 2020
AfroCAB / CHAI Community Consultation and Webinar Series
- Mar 1, 2020
Communique of the Kigali Community Meeting on Dolutegravir and Weight Gain
- Dec 1, 2018
Case Study: Partnering with Communities of PLHIV Accelerates Access to Optimal Treatment
- Nov 1, 2017
Optimal ARV Community Advisory Board Terms of Reference